Vaccinia virus (ATCC® VR-2047)

Classification: Poxviridae, Orthopoxvirus  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Poxviridae, Orthopoxvirus
Agent Vaccinia virus
Strain vP-13
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCC VR-2053) by in vivo recombination. No expression of the insert has been detected.
Product Format frozen
Storage Conditions -70°C or colder
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Comments
Recombinant vaccinia containing the Hhal hepatitis B fragment coding for HBV surface antigen.
A HhaI fragment encoding HBsAg was cloned into vP-8 (ATCC VR-2053) by in vivo recombination. No expression of the insert has been detected.
Effect on Host
Yes, in vitro effects: Cytopathic effects in tissue culture
CPE.
Effect on Host
Yes, in vitro effects: Cytopathic effects in tissue culture
CPE.
Name of Depositor E Paoletti
U.S. Patent
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
References

Paoletti E, Panicali D. Modified vaccinia virus. US Patent 4,603,112 dated Jul 29 1986

Paoletti E, Panicali D. Method for immunizing animals with synthetically modified vaccinia virus. US Patent 4,722,848 dated Feb 2 1988

Panicali D, et al. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37: 1000-1010, 1981. PubMed: 6262520

Hammon WM, et al. Isolation and characterization of prototype viruses ECHO-26, ECHO-27, Coxsackie B-6. Proc. Soc. Exp. Biol. Med. 103: 164-168, 1960. PubMed: 14399342

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • USDA APHIS VS 16-6 or 16-6A permit must be obtained and a copy of the permit must be sent to ATCC in advance of shipment. The Application Form VS 16-3 (Import controlled material import or transport organisms or vectors) must be submitted to USDA APHIS Veterinary Services to obtain the VS 16-6 or 16-6A permit.
  • Customer Acceptance of Responsibility, ATCC Form 62 required for distribution.
  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation